{
    "nctId": "NCT06642441",
    "briefTitle": "Effect of Vitamin D Supplementation on Chemotherapy Side Effects After Adjuvant Chemotherapy for Breast Cancer",
    "officialTitle": "Effect of Vitamin D Supplementation on Chemotherapy Side Effects After Adjuvant Chemotherapy for Breast Cancer",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Vitamin D, Chemotherapy, Breast Cancer, Adverse Reaction",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Incidence and proportion of treatment-related adverse events",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age between 18 and 80 years, with an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2.\n2. Primary diagnosis of breast cancer confirmed by preoperative pathological examination.\n3. Serum 25(OH)D levels less than 20 ng/ml (50 nmol/L).\n4. Patients who have not previously received chemotherapy and who plan to undergo at least 4 cycles of\n5. Patients with adjuvant chemotherapy or combined targeted therapy.\n6. Life expectancy of at least 6 months.\n7. No other uncontrolled benign diseases at the time of recruitment.\n8. All patients must have complete clinical medical records.\n9. Willingness to voluntarily sign an informed consent form.\n\nExclusion Criteria:\n\n1. History of invasive breast cancer.\n2. Prior systemic treatment for the treatment or prevention of breast cancer.\n3. Known allergic reactions to vitamin D or calcium compounds.\n4. Comorbidities that may affect vitamin D or calcium balance or bone health.\n5. Vitamin D or calcium supplementation in the past 3 months.\n6. Presence of other tumors.\n7. Pregnant or lactating women.\n8. Individuals who do not wish to participate in the study.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}